Noninvasive Magnetic Resonance Spectroscopic Pharmacodynamic Markers of the Choline Kinase Inhibitor MN58b in Human Carcinoma Models

Cancer Research - United States
doi 10.1158/0008-5472.can-05-1338
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Dynamic Contrast-Enhanced Magnetic Resonance Imaging as a Pharmacodynamic Biomarker for Pazopanib in Metastatic Renal Carcinoma

Clinical Genitourinary Cancer
OncologyUrology
2017English

Noninvasive Assessment of the Injured Human Spinal Cord by Means of Functional Magnetic Resonance Imaging

Spinal Cord
MedicineNeurologyRehabilitation
2004English

Noninvasive Nuclear Magnetic Resonance Profiling of Painting Layers

Applied Physics Letters
AstronomyPhysics
2008English

Identification of a Unique Inhibitor-Binding Site on Choline Kinase

English

Structural and Spectroscopic Study of the Tyrosine Kinase Inhibitor PD-153035

Biophysical Journal
Biophysics
2019English

Clinical Pharmacokinetic and Pharmacodynamic Overview of Nilotinib, a Selective Tyrosine Kinase Inhibitor

Journal of Clinical Pharmacology
Pharmacology
2018English

Metabolic Shifts Induced by Fatty Acid Synthase Inhibitor Orlistat in Non-Small Cell Lung Carcinoma Cells Provide Novel Pharmacodynamic Biomarkers for Positron Emission Tomography and Magnetic Resonance Spectroscopy

Molecular Imaging and Biology
Cancer ResearchNuclear MedicineRadiologyImagingOncology
2012English

Magnetic Resonance Imaging of Ductal Carcinoma in Situ

Breast Cancer Research
Cancer ResearchOncology
2008English

Magnetic Resonance Perfusion Measurements for the Noninvasive Detection of Coronary Artery Disease

Circulation
Cardiovascular MedicinePhysiologyCardiology
2003English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy